Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Tumors Characterized by Genetic Alterations in Anaplastic Lymphoma Kinase (ALK) × ceritinib × 30 days × Clear all

Sponsor

Conditions

Neuroblastoma 2 Neoplasms 1 Melanoma 1 Lung Neoplasms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡